Want to see IN:BIOCON full AI Analyst Report?
Biocon Limited (BIOCON) Financial Statements
Biocon Limited Financial Overview
Biocon Limited's market cap is currently $573.10B. The company's EPS TTM is $3.40; its P/E ratio is 103.47; and it has a dividend yield of 0.14%. Biocon Limited is scheduled to report earnings on November 4, 2026, and the estimated EPS forecast is $1.04. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 169.27B | $ 152.62B | $ 147.56B | $ 111.74B | $ 81.84B |
| Gross Profit | $ 58.85B | $ 92.44B | $ 91.73B | $ 69.62B | $ 50.11B |
| Operating Income | $ 14.99B | $ 47.20B | $ 50.83B | $ 33.30B | $ 20.04B |
| EBITDA | $ 33.95B | $ 32.30B | $ 33.52B | $ 26.77B | $ 19.73B |
| Net Income | $ 3.86B | $ 10.13B | $ 10.22B | $ 4.63B | $ 6.48B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 38.83B | $ 49.24B | $ 25.74B | $ 37.26B | $ 29.65B |
| Total Assets | $ 636.51B | $ 587.97B | $ 560.71B | $ 520.43B | $ 203.94B |
| Total Debt | $ 154.34B | $ 183.62B | $ 162.77B | $ 180.19B | $ 51.47B |
| Net Debt | $ 122.41B | $ 151.35B | $ 150.43B | $ 166.95B | $ 44.84B |
| Total Liabilities | $ 270.29B | $ 310.85B | $ 307.96B | $ 295.54B | $ 109.24B |
| Stockholders' Equity | $ 340.32B | $ 216.44B | $ 197.84B | $ 178.67B | $ 84.33B |
| Cash Flow | |||||
| Free Cash Flow | $ -5.21B | $ 17.18B | $ 10.22B | $ 1.26B | $ -7.48B |
| Operating Cash Flow | $ 12.77B | $ 40.61B | $ 29.54B | $ 18.52B | $ 11.77B |
| Investing Cash Flow | $ -80.30B | $ -2.34B | $ -10.04B | $ -142.82B | $ -16.99B |
| Financing Cash Flow | $ 57.42B | $ -18.54B | $ -23.33B | $ 130.49B | $ 2.42B |
Currency in INR